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Editorial on the Research Topic
NETosis 2: The Excitement Continues
iNtrodUCtioN
Chromatin externalization to form extracellular traps has first been described in neutrophils 
(1) but can also be observed in mast cells (Mollerherm et  al.) as well as in other myeloid cells 
like eosinophils and basophils (2). DNA externalization-based defense emerged more than 1 
billion years ago. Sentinel cells of the social ameba Dictyostelium discoideum release redundant 
mitochondrial DNA and in an altruistic manner chromatin that sequester colony invading 
bacteria (Zhang and Soldati). Leukotoxic hypercitrullination and deficient mitophagy can initi-
ate mitochondrial DNA expulsion (Konig and Andrade). These processes can be discriminated 
from canonical NET formation (1). However, since they cause DNA externalization they could be 
considered non-canonical forms of NET formation. Although the generation of reactive oxygen 
species is reportedly involved in several pathways of NET formation it is not strictly required for 
others (3). Furthermore, under hypoxic conditions, the PMA-induced NET formation is reported 
to be reduced, though not abrogated (Branitzki-Heinemann et  al.). This editorial summarizes 
the collection of articles of the research topic “NETosis 2, the excitement continues.”
to diE or Not to diE
There is ongoing discussion whether the neutrophils are still viable when they release their chro-
matin and if they release chromatin at all. There are reports that claim the cells mainly external-
ize mitochondrial DNA (Yousefi and Simon). Some investigators question the notion that NETs 
form by cytolysis. They argue that it seems inconsistent with neutrophil “containment” processes 
(Malachowa et al.). Furthermore, the term “NETosis” has been criticized by some researchers who 
prefer the term “NET formation.”
Surveying the published data, including those published in this special issue, we want to sum-
marize the current knowledge (I) Depending on the stimulus, NET formation can be a lytic death 
process eventually leading to disintegration of the neutrophil or a process where neutrophils 
remain migratory and impermeable to ionic dyes; (II) these processes have been observed in vitro 
as well as in vivo; (III) the inducer and its concentration determine, at least in part, these processes 
as well as the content of the NETs. For purposes of this review, we will use the term NET formation 
rather than NETosis to include the various forms of this cellular processes as described by various 
research groups.
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iNdUCErS oF NEt ForMatioN
NET formation is favored by the higher pH at the borders of 
inflamed areas (Maueroder et  al.). The neutrophil granule-
derived enzyme peptidylarginine deiminase type 4 has been 
proposed to be involved in the formation of NETs and its 
pharmacological inhibition suppresses chromatin deconden-
sation and NET formation following certain types of stimuli 
(Kusunoki et  al.). In response to hyphae of Candida albicans 
or immobilized β-glucan neutrophils that are associated with 
the extracellular matrix rapidly form NETs independent of their 
ability to perform an oxidative burst (O’Brien and Reichner). 
The pathway of immune complexes to induce NET formation 
involves cross-linking of the receptor for IgG Fc fragments 
FcγRIIIb, the TGF-β-activated kinase 1, and activation of 
MEK/ERK signaling (Aleman et  al.). NET formation is also 
triggered by interaction of neutrophils with platelets (Carestia 
et  al.) and by a complex interplay between neutrophils and 
bacterial lipopolysaccharides (LPS). Both “suicidal” and “vital” 
NET formation depend on the bacterial origin of the LPS and 
are modulated by the presence or absence of platelets (Pieterse 
et  al.). NETs generated in the presence of propylthiouracil 
display a disordered phenotype which renders them resistant 
to treatment with DNaseI, and have been proposed to favor 
the generation of ANCAs (Soderberg and Segelmark). During 
gestation, the capacity to form NETs increases and involves 
chorionic gonadotropin, G-CSF, and estrogen (Giaglis et al.).
iNHiBitorS oF NEt ForMatioN
The increased capacity to form NETs during gestation is 
controlled by the inhibitory activity of progesterone. This 
hormone reduces the nuclear translocation of the neutrophil 
elastase leading to decreased NET formation (Giaglis et  al.). 
Furthermore, Raloxifene, a selective modulator of the recep-
tor for estrogen prevents NET formation induced by PMA 
(Flores et al.).
NEt CoMPoNENtS
The NET backbones mainly consist of chromatin with modi-
fied, often citrullinated, histones and is overall similar in most 
NETs reported. However, there are considerable differences in 
their protein cargo (Mitsios et al.). These proteins may either 
be derived from the neutrophils’ granules, from the vicinity 
of the NETs or from bystander cells. Neutrophils are endowed 
with a “tool kit” for alternative complement activation. They 
secrete properdin and deposit C3-derived complement frag-
ments on NETs and on NET-bound bacteria (Yuen et  al.). 
Since NETs are endowed with a potent toxic and proteolytic 
armament they need regulatory components to limit tissue 
injury. Hence, the secretory leukocyte protease inhibitor SLPI 
is bound to NETs. However, SLPI-NETs carry a certain risk; 
interacting with plasmacytoid dendritic cells, they induce type 
1 interferon in vitro, cytokines that have been associated with 
the development of various autoimmune conditions (Majewski 
et al.). Extracellular histones are cytotoxic to endothelial cells 
and thus may contribute to septic pathology and death. The 
NET component long pentraxin PTX3 protects against histone-
mediated cytotoxicity (Daigo et al.).
tHE rolES oF HiStoNES
Histones are endowed with bactericidal and fungicidal activi-
ties. This comes at the prize of bystander cytotoxicity toward 
endothelial cells. Thus, extracellular histones are partially 
responsible for tissue damage and septic death. To dampen 
overwhelming histone toxicity, NETs can be decorated with 
the long pentraxin PTX3 that limits histone-mediated tissue 
damage (Daigo et  al.). Antibodies against posttranslational 
modified, citrullinated histones are pathognomonic for patients 
with rheumatoid arthritis (Neeli and Radic). In contrast to 
humans, some autoimmune mice are tolerant to citrullinated 
histones (Dwivedi et  al.), a finding that highlights differ-
ences in PAD4 expression in human versus mouse antigen- 
presenting cells.
aNtiBodiES BiNdiNG NEts aNd  
tHEir CoMPoNENtS
Deimination is a physiological process that is amplified at 
sites of inflammation. However, only individuals with genetic 
predispositions for rheumatoid arthritis develop antibod-
ies against deiminated proteins (ACPAs) (Corsiero et  al.). 
Patients with malaria show circulating NET-binding P-ANCA 
(anti-MPO) and to a lesser extend C-ANCA (anti-PR3) which 
does not react with NETs. This supports the notion that 
NETs are involved in the etiopathogenesis of this, often fatal, 
disease (Boeltz et  al.). Excessive NET formation in Balb/c 
wild type mice leads to generation of MPO-ANCA produc-
tion in  vivo (Kusunoki et  al.). Importantly, the autoantibody 
binding to NETs may not only contribute to immune pathol-
ogy but may aid in the clearance of NETs (Soderberg and 
Segelmark).
MEtHodS For tHE aNalYSiS oF NEts
In general, NETs can be detected by staining of DNA and its 
co-localization with granular and modified nuclear proteins 
in web-like, spiky or cloudy structures, exceeding the size of 
a neutrophil. In neutrophil-rich areas like inflamed synovium 
or densely infiltrated tissues, these NETs tend to aggregate 
(4, 5) and form extended chromatin clumps decorated with an 
effective pathogenocidal armament (Brinkmann et al.). When 
exploring intravascular NET formation in disease, the triad 
neutrophils, platelets, and endothelium should be analyzed 
(Kazzaz et  al.). For in  vitro and ex vivo assays, the medium 
composition has to be precisely reported and strictly controlled 
during the entire assay and not just at its beginning (Maueroder 
et  al.). Detection of deiminated histones is often used as an 
indication of NETosis but it should be stressed that the current 
methods for detection of citrullinated proteins require further 
optimization (Daigo et al.).
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BarriEr FUNCtioN oF aGGrEGatEd 
NEts
NETs generated at high neutrophil densities often aggregate 
and form extended matted structures (4, 5) decorated with a 
plethora of bactericidal and fungicidal molecules. Though these 
structures are based on a DNA meshwork, they only display a 
limited sensitivity against DNA degrading enzymes. Indeed, 
gouty tophi, an aggregate of NETs and MSU crystals, can persist 
in human tissues for several years where DNA is still detectable. 
In the periphery of necrotic areas, necrotic cells may recruit 
neutrophils and initiate and/or facilitate the formation of NET-
based surrogate barriers [Bilyy et al.; Biermann et al.].
iNtraVaSCUlar NEt ForMatioN  
aNd VaSCUlar diSEaSES
Intravascular NETs have pro-coagulant activities associated 
to several pathologies (Kimball et  al.). As in SLE, in ANCA 
associated vasculitis, the degradation pathways of NETs are 
perturbed. Due to low DNaseI activity, the degradation of 
intravascular NETs is slow leading to an increased amount of 
circulating NETs (Soderberg and Segelmark). This phenom-
enon may also contribute to the pathogenesis of severe malaria 
(Boeltz et  al.). Similarly, NETs are discussed to contribute to 
the thrombotic pathologies observed in patients with cancer 
(Olsson and Cedervall).
After bone marrow transplantation, the capacity to form 
NETs is reportedly reduced for up to 200  days (Glenn et  al.). 
In an animal model of paw edema by injection of nanodiamonds 
into wild-type mice and in those with deficient capacity for 
oxidative burst and NET formation (Ncf1** mice), the inflam-
matory response resolves in the former and becomes chronic 
in the latter as a result of the failure to dampen the neutrophil- 
driven inflammation (Biermann et  al.). Importantly, ANCA 
in general are reported to drive immune complex-mediated 
pathologies but they may also aid in the clearance of circulating 
NETs or NET remnants (Soderberg and Segelmark).
NEt ForMatioN aNd EXtraVaSCUlar 
diSEaSE
Though NETs have initially been described as mechanism of 
bacterial defense, they must be considered as double-edged 
swords of innate immunity (Yang et  al.). NETs are involved in 
a plethora of pathological conditions including autoimmunity, 
atherosclerosis, cancer, etc. (Mitsios et  al.). Excess neutrophil 
recruitment to the alveolar space and NET formation in lungs 
reportedly cause inflammation and asthma (Akk et  al.). NETs 
can easily expand in the pulmonary alveoli and cause lung injury. 
DNA disintegration by DNase, neutralization of NET proteins, 
anti-histone antibodies, and protease inhibition may alleviate 
NET-associated pathologies (Porto and Stein). Raloxifene, 
a selective modulator of the estrogen receptor inhibits the NET-
based killing of the leading human bacterial pathogen MRSA 
(Flores et al.). Furthermore, it was recognized that viruses induce 
NETs and target these for immune evasion (Schonrich and 
Raftery). Harming of the blood–brain barrier and of neural cells 
by NETs was observed in humans with Alzheimer’s disease and 
in a murine model of this disabling disease (Pietronigro et al.).
tHEraPEUtiC iNtErVENtioNS
NETs are discussed as a source of the citrullinated autoanti-
gens pathognomonic for patients with rheumatoid arthritis 
and for the DNA observed in tissues and in the circulation 
of patients with SLE. Consequently, PAD4 is proposed to be 
a potential therapeutic target for these chronic inflamma-
tory rheumatic diseases (Konig and Andrade). The synthetic 
peptide P140/Lupuzor™ selectively modulates chaperone-
mediated autophagy but not NET formation in sensu stricto 
(Ramirez et  al.). As high fat diet reportedly increases the 
formation of NETs dietary intervention and reduction of 
fat intake may be beneficial in NET-associated disorders 
(Moorthy et al.).
Targeting NET formation as well as NET-associated 
chromatin decondensation may delay the pathogenesis of 
Alzheimer’s disease (Pietronigro et al.), the early inflammatory 
responses to Sendai virus infection (Akk et  al.), and the dis-
seminated intravascular coagulation observed in severe forms 
of malaria (Boeltz et  al.). As already established for patients 
with cystic fibrosis, the clearance with recombinant human 
DNaseI of the NET-associated DNA, the neutralization of NET- 
borne proteins using anti-histone antibodies, as well as 
inhibitors for NET-bound proteases are discussed as therapeu-
tic options for pulmonary diseases involving alveolar NETs in 
Porto and Stein.
From the papers included in this Research Topic, it is evi-
dent that the field of NET research is now more mature and 
sophisticated than even just a few years ago. Physiological 
and disease conditions that induce abundant NET formation 
are now firmly established and experimental methods for 
detection of NETs in  vivo and in  vitro have been carefully 
defined. It is the hope of the authors that the combined efforts 
presented here will contribute to further shape the consensus 
in the field, energize efforts to understand NET biology, 
and lead to novel therapies for major human disorders that 
present with abnormal NET release or impairments in NET 
degradation.
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